Sanmina Corp. Hits New 52-Week High, Surging 146.58% in a Year

Sanmina Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 167.69 on November 4, 2025. This achievement underscores the company's robust performance over the past year, with a remarkable increase of 146.58%, significantly outpacing the S&P 500's growth of 19.89%.
The company's financial metrics reflect a strong market position, characterized by a price-to-earnings (P/E) ratio of 32.00 and a return on equity (ROE) of 12.73%. Sanmina Corp. maintains a low debt-to-equity ratio of -0.22, indicating a solid financial foundation. Additionally, the stock's price-to-book ratio stands at 5.07, suggesting an attractive valuation relative to its peers.

In terms of operational efficiency, Sanmina Corp. reported its highest operating cash flow of USD 473.46 million, alongside a robust interest coverage ratio of 2,673.96. The company has also seen a decrease in raw material costs by 7.22% year-over-year, contributing to its overall financial health. With 100% institutional holdings, Sanmina Corp. demonstrates strong backing from investors with substantial analytical resources.